A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas
Gliomas are the most common type of brain cancer, and among them, glioblastoma multiforme (GBM) is the most prevalent (about 60% of cases) and the most aggressive type of primary brain tumor. The treatment of GBM is a major challenge due to the pathophysiological characteristics of the disease, such...
Main Authors: | Leonardo Delello Di Filippo, Suzana Gonçalves de Carvalho, Jonatas Lobato Duarte, Marcela Tavares Luiz, Jessyca Aparecida Paes Dutra, Geanne Aparecida de Paula, Marlus Chorilli, João Conde |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | Materials Today Bio |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S259000642300131X |
Similar Items
-
How Nanotherapeutic Platforms Play a Key Role in Glioma? A Comprehensive Review of Literature
by: Yang Y, et al.
Published: (2023-07-01) -
New Technological Approaches for Dental Caries Treatment: From Liquid Crystalline Systems to Nanocarriers
by: Marcela Tavares Luiz, et al.
Published: (2023-02-01) -
Polymeric Nanoparticles for the Treatment of Malignant Gliomas
by: Basant Salah Mahmoud, et al.
Published: (2020-01-01) -
Editorial: Medical and Pharmaceutical Applications of Nanomaterials: From Diagnosis to Treatment
by: Shahla Rezaei, et al.
Published: (2024-03-01) -
Encapsulation of miRNA and siRNA into Nanomaterials for Cancer Therapeutics
by: Mina Zare, et al.
Published: (2022-08-01)